5/18
Karen Kreeger
Penn Immunologist to Co-direct $12 Million Grant to Study Hepatitis
John Wherry, PhD, an associate professor of Microbiology in the Perelman School of Medicine at the University of Pennsylvania, and colleagues from Massachusetts General Hospital (MGH) are co-directing a $12 million grant to study immune responses in people who have been effectively cured of hepatitis C viral infection with new, high-potency antiviral drugs.
Karen Kreeger ・
Diabetes Susceptibility Gene Regulates Health of Cell's Powerhouse, Penn Study Finds
A team led by researchers from the Perelman School of Medicine at the University of Pennsylvania found that a susceptibility gene for type 1 diabetes regulates self-destruction of the cell’s energy factory. They report their findings this week in Cell.
Karen Kreeger ・
Penn Study: Genomic "Dark Matter" of Embryonic Lungs Controls Proper Development of Airways
It’s a long way from DNA to RNA to protein, and only about two percent of a person’s genome is eventually converted into proteins.
Karen Kreeger ・
Penn Study Describes New Models for Testing Parkinson's Disease Immune-based Drugs
Using powerful, newly developed cell culture and mouse models of sporadic Parkinson’s disease (PD), a team of researchers from the Perelman School of Medicine at the University of Pennsylvania, has demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain.
Karen Kreeger ・
Penn Medicine Receives Superfund Research Program Award of $10 Million to Study the Adverse Health Effects and Remediation of Asbestos
Researchers at the Center of Excellence in Environmental Toxicology (CEET), Perelman School of Medicine at the University of Pennsylvania, have been awarded a $10 million grant from the National Institute for Environmental Health Sciences (NIEHS) over the next f
Karen Kreeger ・
Quality Control: Penn Study Shows How Misfolded Proteins are Selected for Disposal
It’s almost axiomatic that misfolded proteins compromise how cells normally function and cause debilitating human disease, but how these proteins are detected and degraded within the body is not well understood.
Karen Kreeger ・
"Bystander" Chronic Infections Thwart Development of Immune Cell Memory, Penn Study Finds
Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines for unrelated illnesses.
Karen Kreeger ・
Penn Yeast Study Identifies Novel Longevity Pathway
Ancient philosophers looked to alchemy for clues to life everlasting. Today, researchers look to their yeast. These single-celled microbes have long served as model systems for the puzzle that is the aging process, and in this week’s issue of Cell Metabolism, they fill in yet another piece.
Karen Kreeger ・
Four Researchers From Penn Elected to the American Academy of Arts and Sciences
Four researchers from the University of Pennsylvania have been elected to the American Academy of Arts and Sciences, one of the nation's most prestigious honorary societies and a leading center for independent policy research. The new honorees are:
Katherine Unger Baillie, Karen Kreeger ・
Three Researchers from Penn Medicine Elected to American Academy of Arts and Sciences
Three researchers from the Perelman School of Medicine at the University of Pennsylvania have been elected as new members to the American Academy of Arts and Sciences, one of the nation's most prestigious honorary societies and a leading center for independent policy research.
Karen Kreeger ・